Spots Global Cancer Trial Database for poziotinib once daily dosing or twice daily dosing as determined in phase 1
Every month we try and update this database with for poziotinib once daily dosing or twice daily dosing as determined in phase 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Poziotinib in Japanese Patients With NSCLC | NCT04402008 | NSCLC | Poziotinib Once... Poziotinib Twic... Poziotinib Once... | 20 Years - | Spectrum Pharmaceuticals, Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
